Multiplex Assay Kit for Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay)

CAP 57

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-102 97
EDTA plasma(n=5) 89-101 98
heparin plasma(n=5) 95-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-99% 79-93% 89-101% 79-97%
EDTA plasma(n=5) 78-93% 82-97% 85-101% 96-104%
heparin plasma(n=5) 79-95% 85-94% 84-97% 81-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:BPI) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
The Journal of International Medical Research Effects of Acute Hypervolaemic Haemodilution on the Expression of Plasma Interferon-inducible Protein-10 and Bactericidal/Permeability-increasing Protein in Patients Undergoing Total Hip Replacement Ingenta: art00020
AIDS Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy PubMed: PMC3754419
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB234Hu01 Recombinant Bactericidal/Permeability Increasing Protein (BPI) Positive Control; Immunogen; SDS-PAGE; WB.
RPB234Hu02 Recombinant Bactericidal/Permeability Increasing Protein (BPI) Positive Control; Immunogen; SDS-PAGE; WB.
PAB234Hu01 Polyclonal Antibody to Bactericidal/Permeability Increasing Protein (BPI) WB; IHC; ICC; IP.
PAB234Hu02 Polyclonal Antibody to Bactericidal/Permeability Increasing Protein (BPI) WB; IHC; ICC; IP.
MAB234Hu22 Monoclonal Antibody to Bactericidal/Permeability Increasing Protein (BPI) WB; IHC; ICC; IP.
SEB234Hu ELISA Kit for Bactericidal/Permeability Increasing Protein (BPI) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB234Hu Multiplex Assay Kit for Bactericidal/Permeability Increasing Protein (BPI) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.